
(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Roman around the Christmas tree | Space photo of the day for Dec. 25, 2025 - 2
The most effective method to Pick the Right Material Organization: Fundamental Tips - 3
Pick Your Favored sort of cooking - 4
If evolution is real, then why isn’t it happening now? An anthropologist explains that humans actually are still evolving - 5
From Iran to Israel: An Iranian volunteer’s unlikely stand in wartime
NASA’s Pandora telescope will study stars in detail to learn about the exoplanets orbiting them
Make your choice for a definitive Christmas place to get-away!
Nearly 16,000 New York City nurses prepare to strike as contract talks stall
From Specialist to Proficient Picture taker: Individual Triumphs
The Way to Business: Startup Illustrations Learned
IDF destroys Hezbollah rocket launcher used in large rocket salvo towards Haifa, Galilee
Fundamental Home Exercise center Hardware: Amplify Your Exercises
Presenting Nintendo's New Pastel Bliss Con Tones for Switch Gamers: 3 Smart Choices
Saudi Arabia says it intercepted 7 missiles, debris falls near energy facilities













